Clever Culture Systems Limited
CC5
Rang in Aktien
#27508
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Aktienkurs
$0.0141057
Zuletzt synchronisiert: 2026-10-18
Marktkapitalisierung
$30.78M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
32.83%
Land
AU
Handel Clever Culture Systems Limited (CC5)
Kategorie
Healthcare
Gewinn für Clever Culture Systems Limited (CC5)
Gewinn im Jun 2024 TTM: $-3.12M
Laut den aktuellen Finanzberichten von Clever Culture Systems Limited betragen die aktuellen Gewinne des Unternehmens $-3.12M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $-13.91M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $-5.66M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Clever Culture Systems Limited von 2007 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $-3.12M | 0.00% |
| 2024 | $-3.12M | -77.57% |
| 2023 | $-13.91M | 145.86% |
| 2022 | $-5.66M | 30.43% |
| 2021 | $-4.34M | 11.28% |
| 2020 | $-3.90M | -7.37% |
| 2019 | $-4.21M | 73.60% |
| 2018 | $-2.42M | -67.23% |
| 2017 | $-7.40M | -341.08% |
| 2016 | $3.07M | -1,286.43% |
| 2015 | $-258.70K | -71.75% |
| 2014 | $-915.89K | -370.88% |
| 2013 | $338.11K | -119.00% |
| 2012 | $-1.78M | -10.68% |
| 2011 | $-1.99M | -219.96% |
| 2010 | $1.66M | 689.45% |
| 2009 | $210.37K | -2.53% |
| 2008 | $215.84K | -77.99% |
| 2007 | $980.77K | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.61B | -243,863.06% |
US
|
|
| $4.76B | -152,656.14% |
US
|
|
| $-252.70M | 7,995.57% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -53,215.93% |
US
|
